We are live on
!
Find out more
CFM
Capricorn Fund Managers Portfolio holdings
AUM
$1.27B
1-Year Est. Return
70.17%
This Fund
S&P 500
This Quarter
Est. Return
+15.21%
1 Year Est. Return
+70.17%
3 Year Est. Return
+169.21%
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$1.27B
AUM Growth
+$627M
(+98%)
Cap. Flow
+$530M
Cap. Flow
% of AUM
41.74%
Top 10 Holdings %
Top 10 Hldgs %
26.97%
Holding
219
New
105
Increased
29
Reduced
25
Closed
41
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
LPL Financial
LPLA
|
+$58.5M |
| 2 |
BP
BP
|
+$43.2M |
| 3 |
Shell
SHEL
|
+$39.6M |
| 4 |
Applovin
APP
|
+$29.6M |
| 5 |
ING
ING
|
+$26.6M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Adaptive Biotechnologies
ADPT
|
+$19.4M |
| 2 |
Norfolk Southern
NSC
|
+$17.5M |
| 3 |
Primerica
PRI
|
+$17M |
| 4 |
EA
Electronic Arts
EA
|
+$15.5M |
| 5 |
Phibro Animal Health
PAHC
|
+$14.8M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Financials | 25.12% |
| 2 | Healthcare | 19.47% |
| 3 | Consumer Discretionary | 12.53% |
| 4 | Technology | 12.07% |
| 5 | Communication Services | 7.74% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
201
Moody's
MCO
$85.5B
| – | – |
-2,111
| Closed | -$921K |
|
202
Maravai LifeSciences
MRVI
$1.09B
| – | – |
-339,727
| Closed | -$961K |
|
203
Netflix
NFLX
$326B
| – | – |
-22,260
| Closed | -$2.14M |
|
|
204
Norfolk Southern
NSC
$74B
| – | – |
-61,117
| Closed | -$17.5M |
|
|
205
Phibro Animal Health
PAHC
$1.55B
| – | – |
-267,045
| Closed | -$14.8M |
|
206
Penumbra
PEN
$12.7B
| – | – |
-5,879
| Closed | -$1.93M |
|
|
207
Primerica
PRI
$9.1B
| – | – |
-68,041
| Closed | -$17M |
|
208
RenaissanceRe
RNR
$13.7B
| – | – |
-9,774
| Closed | -$2.91M |
|
209
Constellation Brands
STZ
$21.9B
| – | – |
-15,500
| Closed | -$2.33M |
|
210
Tarsus Pharmaceuticals
TARS
$3.98B
| – | – |
-26,000
| Closed | -$1.82M |
|
211
Thermo Fisher Scientific
TMO
$227B
| – | – |
-540
| Closed | -$265K |
|
212
10x Genomics
TXG
$8.16B
| – | – |
-101,800
| Closed | -$2.16M |
|
213
Vera Therapeutics
VERA
$2.59B
| – | – |
-64,604
| Closed | -$2.6M |
|
214
Virtu Financial
VIRT
$5.69B
| – | – |
-54,668
| Closed | -$2.4M |
|
215
Warner Bros
WBD
$70.8B
| – | – |
-107,939
| Closed | -$2.96M |
|
|
TXNM
216
TXNM Energy Inc
TXNM
$5.98B
| – | – |
-151,009
| Closed | -$8.83M |
|
|
AVR
217
Anteris Technologies
AVR
$881M
| – | – |
-500,525
| Closed | -$2.78M |
|
|
KRMN
218
Karman Holdings
KRMN
$5.3B
| – | – |
-4,281
| Closed | -$343K |
|
|
MDLN
219
Medline Inc
MDLN
$32.1B
| – | – |
-42,455
| Closed | -$1.89M |
|
Similar funds
JLBC
KA
BFS
WA
JMFC
JTWM
MIA
CAM
Capricorn Fund Managers's Q2 2026 Portfolio in Review
As of Q2 2026, Capricorn Fund Managers held 219 positions worth $1.27B, up 98% from $641M the previous quarter. Its ten largest holdings account for 27% of the portfolio.
Capricorn Fund Managers deployed $530M of net new capital in Q2 2026, opening 105 new positions and adding to 29 existing holdings. Its largest new stake was LPL Financial: 194,812 shares worth $54.9M.
By sector, the portfolio is most concentrated in Financials at 25% of assets, up from 20% a quarter earlier, followed by Healthcare and Consumer Discretionary.
On the sell side, the largest reduction was Adaptive Biotechnologies, an estimated $19.4M trimmed.
- Capricorn Fund Managers's largest Q2 2026 buy was LPL Financial: 194,812 shares worth $54.9M.
- Capricorn Fund Managers added most to KKR & Co in Q2 2026, an estimated $24.1M increase.
- Capricorn Fund Managers's biggest Q2 2026 reduction was Adaptive Biotechnologies, cutting an estimated $19.4M.
- Capricorn Fund Managers fully exited Norfolk Southern in Q2 2026, selling an estimated $17.5M.
- Capricorn Fund Managers's ten largest holdings make up 27% of its $1.27B portfolio in Q2 2026.
- Capricorn Fund Managers opened 105 new positions and closed 41 in Q2 2026.
- Capricorn Fund Managers's portfolio value rose 98% quarter-over-quarter to $1.27B.
Based on Capricorn Fund Managers's 13F filing for Q2 2026, filed 24 Jul 2026.